Source: International Business Times
Moderna announces positive results on groundbreaking cancer treatment. Reuters News of a potential personalized cancer vaccine more than doubled the value of Moderna's stock Wednesday. Moderna and Merck jointly announced Wednesday that a late-stage trial produced positive results, CNBC reported.
Aller á la Source
Nouvelles connexes
